Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections

International Journal of Infectious Diseases

Volumn 25, Issue , 2014, Pages 59-64

  Grau, Imma ^a   Ardanuy, Carmen ^a   Calatayud, Laura ^a   Schulze, Marco H ^b   Liñares, Josefina ^a   Pallares, Roman ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Alcohol; Mortality; Pneumonia; Serotypes; Smoking; Streptococcus pneumoniae

Indexed keywords

ALCOHOL; CEFOTAXIME; CEFTRIAXONE; LEVOFLOXACIN; MACROLIDE; VANCOMYCIN;

ADULT; ALCOHOL ABUSE; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NONHUMAN; PERITONITIS; PNEUMOCOCCAL INFECTION; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEROTYPE; SEROTYPING; SEX DIFFERENCE; SMOKING; SMOKING HABIT; YOUNG ADULT; ADOLESCENT; ADVERSE EFFECTS; AGED; ALCOHOLISM; CASE CONTROL STUDY; CLASSIFICATION; COMORBIDITY; COMPLICATION; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE; RISK; SPAIN; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEROGROUP; SMOKING; SPAIN; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84901992487     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.12.013     Document Type: Article

References (31)

1. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005, 294:2043-2051.
2. Kyaw M.H., Rose C.E., Fry A.M., Singleton J.A., Moore Z., Zell E.R., et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005, 192:377-386.
3. Grau I., Ardanuy C., Calatayud L., Rolo D., Domenech A., Liñares J., et al. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden1-ST306. PLoS One 2012, 7:e42595. 10.1371/journal.pone.0042595.
4. Nuorti J.P., Butler J.C., Farley M.M., Harrison L.H., McGeer A., Kolczak M.S., et al. Cigarette smoking and invasive pneumococcal disease. Active bacterial core surveillance team. N Engl J Med 2000, 342:681-689.
5. Benard A., Mercié P., Alioum A., Bonnet F., Lazaro E., Dupon M., et al. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. PLoS One 2010, 5:e8896. 10.1371/journal.pone.0008896.
6. Almirall J., González C.A., Balanzó X., Bolíbar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999, 116:375-379.
7. Cecere L.M., Williams E.C., Sun H., Bryson C.L., Clark B.J., Bradley K.A., et al. Smoking cessation and the risk of hospitalization for pneumonia. Respir Med 2012, 106:1055-1062.
8. Gordin F.M., Roediger M.P., Girard P.M., Lundgren J.D., Miro J.M., Palfreeman A., et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008, 178:630-636.
9. Kornum J.B., Due K.M., Nørgaard M., Tjønneland A., Overvad K., Sørensen H.T., et al. Alcohol drinking and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2012, 39:149-155.
10. Samokhvalov A.V., Irving H.M., Rehm J. Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect 2010, 138:1789-1795.
11. Fernandez-Sola J., Junque A., Estruch R., Monforte R., Torres A., Urbano-Marquez A. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 1995, 155:1649-1654.
12. Feldman C., Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect 2013, 67:169-184.
13. Mutepe N.D., Cockeran R., Steel H.C., Theron A.J., Mitchell T.J., Feldman C., et al. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Eur Respir J 2013, 41:392-395.
14. Greenberg D., Givon-Lavi N., Broides A., Blancovich I., Peled N., Dagan R. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis 2006, 42:897-903.
15. Siggins R.W., Melvan J.N., Welsh D.A., Bagby G.J., Nelson S., Zhang P. Alcohol suppresses the granulopoietic response to pulmonary Streptococcus pneumoniae infection with enhancement of STAT3 signaling. J Immunol 2011, 186:4306-4313.
16. Burnham E.L., Gaydos J., Hess E., House R., Cooper J. Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage. Alcohol Alcohol 2010, 45:414-421.
17. Raasch C.E., Zhang P., Siggins R.W., LaMotte L.R., Nelson S., Bagby G.J. Acute alcohol intoxication impairs the hematopoietic precursor cell response to pneumococcal pneumonia. Alcohol Clin Exp Res 2010, 34:2035-2043.
18. Mehta A.J., Guidot D.M. Alcohol abuse, the alveolar macrophage and pneumonia. Am J Med Sci 2012, 343:244-247.
19. Boe D.M., Nelson S., Zhang P., Quinton L., Bagby G.J. Alcohol-induced suppression of lung chemokine production and the host defense response to Streptococcus pneumoniae. Alcohol Clin Exp Res 2003, 27:1838-1845.
20. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2013. Ann Intern Med 2013;158:191-9.
21. Pallares R., Capdevila O., Liñares J., Grau I., Onaga H., Tubau F., et al. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am J Med 2002, 113:120-126.
22. Grau I., Pallares R., Tubau F., Schulze M.H., Llopis F., Podzamczer D., et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005, 165:1533-1540.
23. Vila-Corcoles A., Ochoa-Gondar O., Ester F., Sarra N., Ansa X., Saun N. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health 2006, 6:231. EVAN Study Group.
24. Vila-Corcoles A., Ochoa-Gondar O., Rodriguez-Blanco T., Gutierrez-Perez A., Vila-Rovira A. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study. Hum Vaccin Immunother 2012, 8:639-644. EPIVAC Study Group.
25. Vila-Corcoles A., Ochoa-Gondar O., Gutierrez-Perez A., Salsench E., de Diego C., Gonzalez-Lamban B. Evolution of the antipneumococcal vaccination coverage among children in the region of Tarragona, Spain, 2002-2011. Rev Esp Salud Publica 2012, 86:637-643.
26. Agencia de Salut Publica de Catalunya. Enquesta de salut de Catalunya 2011. Departament Salut, Generalitat de Catalunya; 2011. Available at: . (accessed February 15, 2013). http://www20.gencat.cat/docs/salut/Home/El%20Departament/Estadistiques%20sanitaries/Enquestes/02_enquesta_catalunya_continua/Documents/informeesca2011.pdf.
27. Sá-Leão R., Pinto F., Aguiar S., Nunes S., Carriço J.A., Frazão N., et al. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 2011, 49:1369-1375.
28. Ladhani S.N., Slack M.P., Andrews N.J., Waight P.A., Borrow R., Miller E. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis 2013, 19:61-68.
29. Fenoll A., Aguilar L., Vicioso M.D., Gimenez M.J., Robledo O., Granizo J.J., et al. Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008. Antimicrob Agents Chemother 2010, 54:5387-5390.
30. van Hoek A.J., Andrews N., Waight P.A., Stowe J., Gates P., George R., et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 2012, 65:17-24.
31. Vernatter J., Pirofski L.A. Current concepts in host-microbe interaction leading to pneumococcal pneumonia. Curr Opin Infect Dis 2013, 26:277-283.